ClinicalTrials.gov
ClinicalTrials.gov Menu

Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (Nabi-HB-SC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00800787
Recruitment Status : Withdrawn (New sponsor's existing product under evaluation for this indication)
First Posted : December 2, 2008
Last Update Posted : January 18, 2016
Sponsor:
Information provided by (Responsible Party):
Biotest Pharmaceuticals Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : August 2010
  Estimated Study Completion Date : September 2010